The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Abdullayev O.A.

Novosibirsk State Medical University Ministry of Health, Novosibirsk, Russia;
European Medical Center, Moscow, Russia

Gaĭtan A.S.

Novosibirskiĭ NII patologii krovoobrashcheniia im. akad. E.N. Meshalkina

Salim N.

European Medical Center, Moscow, Russia

Sergeev G.S.

GBOU VPO "Novosibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet"

Marmazeyev I.V.

European Medical Center, Moscow, Russia

Chesnulis E.

Hirslanden Clinic, Center of Neurosurgery, Zurich, Switzerland

Goriaĭnov S.A.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Krivoshapkin A.L.

Repetitive resection and intrasurgery radiation therapy of brain malignant gliomas: history of question and modern state of problem

Authors:

Abdullayev O.A., Gaĭtan A.S., Salim N., Sergeev G.S., Marmazeyev I.V., Chesnulis E., Goriaĭnov S.A., Krivoshapkin A.L.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2019;83(5): 101‑108

Read: 9189 times


To cite this article:

Abdullayev OA, Gaĭtan AS, Salim N, et al. Repetitive resection and intrasurgery radiation therapy of brain malignant gliomas: history of question and modern state of problem. Burdenko's Journal of Neurosurgery. 2019;83(5):101‑108. (In Russ., In Engl.)
https://doi.org/10.17116/neiro201983051101

Recommended articles:
Glymphatic system in health and disease: a narrative review. Burdenko's Journal of Neurosurgery. 2025;(4):112-118
Post-radiation choroidal mela­noma pathomorphosis asse­ssment in clinical practice. Russian Journal of Archive of Pathology. 2025;(3):33-39
Lean mana­gement example at the radiotherapy depa­rtment. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):67-73
Prevention and treatment of dermal toxi­city in children receiving anti-tumor radiation. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):470-480
Proton therapy of skull base chordoma. P.A. Herzen Journal of Onco­logy. 2025;(5):64-67

References:

  1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica. 2016;131(6):803-820. https://doi.org/10.1007/s00401-016-1545-1
  2. Stupp R, Tonn JC, Brada M., Pentheroudakis G. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2010;21(Suppl 5):v190-v193. https://doi.org/10.1093/annonc/mdq187
  3. Goryaynov SA, Gol’dberg MF, Golanov AV, Zolotova SV, Shishkina LV, Ryzhova MV, Pitskhelauri DI, Zhukov VYu, Usachev DYu, Belyaev AYu, Kondrashov AV, Shurkhay VA, Potapov AA. The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R132H). Voprosy neirokhirurgii im. N.N. Burdenko. 2017;81(3):5-16. (In Russ.) https://doi.org/10.17116/neiro20178135-16
  4. Haj A, Doenitz C, Schebesch K, Ehrensberger D, Hau P, Putnik K, Riemenschneider MJ, Wendl C, Gerken M, Pukrop T, Brawanski A, Proescholdt M. Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center. Brain Sciences. 2018;8(1):5. https://doi.org/10.3390/brainsci8010005
  5. Hardesty DA, Sanai N. The Value of Glioma Extent of Resection in the Modern Neurosurgical Era. Frontiers in Neurology. 2012;3:140. https://doi.org/10.3389/fneur.2012.00140
  6. Krivoshapkin AL, Sergeev GS, Gaytan AS, Kurbatov VP, Kiselev RS, Kalneus LE. Impact of pre- and postoperative tumor volumetric data on survival of patiens with glioblastomas. Vestnik nevrologii, psikhiatrii i neyrokhirurgii. 2016;(6):59-67. (In Russ.)
  7. Krivoshapkin AL, Sergeev GS, Gaytan AS, Kurbatov VP, Kalneus LE, Tarantsev IG. New software for objective evaluation of brain glioblastoma resection degree. Voprosy neirokhirurgii im. N.N. Burdenko. 2014;78(5):33-40. (In Russ)
  8. Davis ME. Glioblastoma: Overview of Disease and Treatment. Clinical Journal of Oncology Nursing. 2016;20(5):S2-S8. https://doi.org/10.1188/16.CJON.S1.2-8
  9. Martínez-Garcia M, Álvarez-Linera J, Carrato C, Ley L, Luque R, Maldonado X, Martínez-Aguillo M, Navarro LM, Vaz-Salgado MA, Gil-Gil M. SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017). Clinical and Translational Oncology. 2018;20(1):22-28. https://doi.org/10.1007/s12094-017-1763-6
  10. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. International Journal of Radiation Oncology Biology Physics. 1989;16(6):1405-1409.
  11. Gaspar LE, Fisher BJ, Macdonald DR, LeBer DV, Halperin EC, Schold SC Jr, Cairncross JG. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. International Journal of Radiation Oncology Biology Physics. 1992;24(1):55-57.
  12. Choucair AK, Levin VA, Gutin PH, Davis RL, Silver P, Edwards MS, Wilson CB. Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. Journal of Neurosurgery. 1986;65(5):654-658. https://doi.org/10.3171/jns.1986.65.5.0654
  13. Mallick S, Benson R, Hakim A, Rath GK. Management of glioblastoma after recurrence: A changing paradigm. Journal of the Egyptian National Cancer Institute. 2016;28(4):199-210. https://doi.org/10.1016/j.jnci.2016.07.001
  14. Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen J-M. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. The Lancet. Oncology. 2017;18:e315-e329. https://doi.org/10.1016/S1470-2045(17)30194-8
  15. Ringel F, Pape H, Sabel M, Krex D, Bock HC, Misch M, Simon M. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. Neuro-Oncology. 2016;18:96. https://doi.org/10.1093/neuonc/nov145
  16. van Linde ME, Brahm CG, de Witt Hamer PC, Reijneveld JC, Bruynzeel AME, Vandertop WP, van de Ven PM, Wagemakers M, van der Weide HL, Enting RH, Walenkamp AME, Verheul HMW. Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis. Journal of Neuro-Oncology. 2017;135(1):183. https://doi.org/10.1007/s11060-017-2564-z
  17. Landy HJ, Feun L, Schwade JG, Snodgrass S, Lu Y, Gutman F. Retreatment of intracranial gliomas. Southern Medical Journal. 1994;87:211-214.
  18. Ammirati M, Galicich JH, Arbit E, Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 1987;21:607-614.
  19. Harsh GR, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery. 1987;21:615-621.
  20. Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Rudà R, Marosi C, Le Rhun E, Grant R, Oliver K, Oberg I, Bulbeck HJ, Rooney AG, Henriksson R, Pasman HRW, Oberndorfer S, Weller M, Taphoorn MJB; European Association of Neuro-Oncology palliative care task force. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. The Lancet. Oncology. 2017;18(6):e330-e340. https://doi.org/10.1016/S1470-2045(17)30345-5
  21. Lederman G, Wronski M, Arbit E. Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. American Journal of Clinical Oncology. 2000;23:155-159.
  22. Young B, Oldfield EH, Markesbery WR, Haack D, Tibbs PA, McCombs P, Meacham WF. Reoperation for glioblastoma. Journal of Neurosurgery. 1981;55:917-921. https://doi.org/10.3171/jns.1981.55.6.0917
  23. Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Parsa AT. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. Journal of Neurosurgery. 2012;117:1032-1038. https://doi.org/10.3171/2012.9.JNS12504
  24. Park CK, Kim JH, Nam DH, Kim CY, Chung SB, Kim YH, Seol HJ, Kim TM, Choi SH, Lee SH, Heo DS, Kim IH, Kim DG, Jung HW. A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma. Neuro-Oncology. 2013;15(8):1096-101. https://doi.org/10.1093/neuonc/not069
  25. Veldwijk MR, Zhang B, Wenz F, Herskind C. The biological effect of large single doses: a possible role for non-targeted effects in cell inactivation. PLoS One. 2014;9(1):e84991. https://doi.org/10.1371/journal.pone.0084991
  26. Herskind C, Wenz F. Radiobiological aspects of intraoperative tumour-bed irradiation with low-energy X-rays (LEX-IORT). Translational Cancer Research. 2014;3(1):3-17. https://doi.org/10.3978/j.issn.2218-676X.2014.01.06
  27. Abe M, Fukuda M, Yamano K, Matsuda S, Handa H. Intra-Operative Irradiation in Abdominal and Cerebral Tumours. Acta Radiologica: Therapy, Physics, Biology. 1971;10:408-416. https://doi.org/10.3109/02841867109130786
  28. Sakai N, Yamada H, Andoh T, Hirata T, Nishimura Y, Miwa Y. Intraoperative radiation therapy for malignant glioma. Neurologia Medico-Chirurgica. 1991;31(11):702-707.
  29. Matsutani M, Nakamura O, NagashimaT, Asai A, Fujimaki T, Tanaka H. Intra-operative radiation therapy for malignant brain tumors: rationale, method, and treatment results of cerebral glioblastomas. Acta Neurochirurgica. 1994;131(1-2):80-90. https://doi.org/10.1007/BF01401457
  30. Fujiwara T, Honma Y, Ogawa T, Irie K, Kuyama H, Nagao S, Tanabe M. Intraoperative radiotherapy for gliomas. Journal of Neuro-Oncology.1995;23:81-86. https://doi.org/10.1007/BF01058463
  31. Nemoto K, Ogawa Y, Matsushita H, Takeda K, Takai Y, Yamada S. Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas. BMC Cancer. 2002;2:1. https://doi.org/10.1186/1471-2407-2-1
  32. Ortiz de Urbina D, Santos M, Garcia-Berrocal I, Bustos JC, Samblas J, Gutierrez-Diaz JA. Intraoperative radiation therapy in malignant glioma: early clinical results. Neurological Research. 1995;17(4):289-294.
  33. Schueller P, Micke O, Palkovic S, Schroeder J, Moustakis C, Bruns F. 12 years’ experience with Intraoperative radiotherapy (IORT) of malignant gliomas. Strahlentherapie und Onkologie. 2005;181(8):500-506. https://doi.org/10.1007/s00066-005-1354-2
  34. Takakura K, Kubo O. Treatment of malignant brain tumors. Gan To Kagaku Ryoho. Cancer and Chemotherapy. 2000;27(Suppl 2):449-453.
  35. Zamzuri I, Rahman GI, Muzaimi M, Jafri AM, Nik Ruzman NI, Lutfi YA. Polymodal therapy for high grade gliomas: a case report of favorable outcomes following intraoperative radiation therapy. Medical Journal of Malaysia. 2012;67(1):121-122.
  36. Monroe JI, Dempsey JF, Dorton JA, Mutic S, Stubbs JB, Markman J, Williamson JF. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator. Medical Physics. 2001;28(1):73-85. https://doi.org/10.1118/1.1334608
  37. Timothy A, Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. International Journal of Radiation Oncology, Biology, Physics. 2005;62(4):1133-1139. https://doi.org/10.1016/j.ijrobp.2004.12.032
  38. Giordano FA, Abo-Madyan Y, Brehmer S, Herskind C, Sperk E, Schneider F, Clausen S, Welzel G, Schmiedek P, Wenz F. Intraoperative radiotherapy (IORT) — a resurrected option for treating glioblastoma? Translational Cancer Research. 2014;3(1):94-105. https://doi.org/10.3978/j.issn.2218-676X.2014.01.03
  39. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine. 2005;352(10):987-996. https://doi.org/10.1056/NEJMoa043330
  40. Giordano FA, Brehmer S, Abo-Madyan Y, Welzel G, Sperk E, Keller A. INTRAGO: intraoperative radiotherapy in glioblastoma multiforme-a Phase I/II dose escalation study. BMC Cancer. 2014;14(1):992. https://doi.org/10.1186/1471-2407-14-992
  41. Bensaleh S, Bezak E, Borg M. Review of MammoSite brachytherapy: advantages, disadvantages and clinical outcomes. Acta Oncologica. 2009;48(4):487-494. https://doi.org/10.1080/02841860802537916
  42. Scanderbeg DJ, Alksne JF, Lawson JD, Murphy KT. Novel use of the Contura for high dose rate cranial brachytherapy. Medical Dosimetry. 2011;36(4):344-346. https://doi.org/10.1016/j.meddos.2010.08.001
  43. Ramachandran P. New era of electronic brachytherapy. World Journal of Radiology. 2017;9(4):148-154. https://doi.org/10.4329/wjr.v9.i4.148
  44. Schwartzberg BS, Chin DT, Dorn PL, Herron DS, Howell KT, Kemmis TJ, Miller SA, Moore JA, Paul D. Application of 21-Gene Recurrence Score Results and ASTRO Suitability Criteria in Breast Cancer Patients Treated with Intraoperative Radiation Therapy (IORT). American Journal of Surgery. 2018;216(4):689-693. https://doi.org/10.1016/j.amjsurg.2018.07.022
  45. Silverstein MJ, Epstein M, Kim B, Lin K, Khan S, Snyder L, Guerra L, Coleman C, Chen P. Intraoperative Radiation Therapy (IORT): A Series of 1000 Tumors. Annals of Surgical Oncology. 2018;25(10):2987-2993. https://doi.org/10.1245/s10434-018-6614-3
  46. Lozares-Cordero S, Font-Gómez JA, Gandía-Martínez A, Méndez-Villamón A. Postoperative endometrial cancer treatments with electronic brachytherapy source. Journal of Radiotherapy in Practice. 2019;18(1):16-20. https://doi.org/10.1017/S1460396918000353
  47. Patel R, Strimling R, Doggett S, Willoughby M, Miller K, Dardick L, Mafong E. Comparison of Electronic Brachytherapy and Mohs Micrographic Surgery for the Treatment of Early-Stage Non-Melanoma Skin Cancer: a Matched Pair Cohort Study. Journal of Contemporary Brachytherapy. 2017;4:338-344. https://doi.org/10.5114/jcb.2017.68480
  48. Goyal U, Pan J, Cui H, Stea B. Does Ultrasound Measurement Improve the Accuracy of Electronic Brachytherapy in the Treatment of Superficial Non-Melanomatous Skin Cancer? Journal of Contemporary Brachytherapy. 2017;1:14-19. https://doi.org/10.5114/jcb.2017.65476

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.